Skip to main content
. Author manuscript; available in PMC: 2016 May 24.
Published in final edited form as: Pediatr Infect Dis J. 2015 May;34(5):e113–e118. doi: 10.1097/INF.0000000000000630

Table 2.

Adverse events to meningococcal C conjugate vaccine immunization within 20 minutes, and at 3 and 7 days (N = 204).

Adverse event* HIV infected
group
(n = 154)
HIV-uninfected
group
(n = 50)
p-value
Immediate - total 30 (19.48%) 8 (16%) 0.78
Local reaction 24 (15.58%) 8 (16%) 0.84
Systemic reactions 10 (6.49%) 0 0.17
Within 3 days - total 42 (27.27%) 3 (6%) < 0.01
Fever 5 (3.25%) 0 0.45
Local reaction 32 (20.78%) 3 (6%) 0.07
Systemic reactions 16 (10.39%) 0 0.07
Within 7 days - total 15 (9.74%) 1 (2%) 0.09
Fever 2 (1.30%) 0 0.72
Local reaction 4 (2.60%) 1 (2%) 0.84
Systemic reactions 13 (8.44%) 0 0.09
Total 66 (42.86%) 10 (20%) < 0.01
*

All local reactions were mild (grade 1). No grade ≥ 3 adverse events were reported.